PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SINT vs. THAR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SINT and THAR is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SINT vs. THAR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sintx Technologies, Inc. (SINT) and Tharimmune Inc. (THAR). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-50.00%
-36.36%
SINT
THAR

Key characteristics

Sharpe Ratio

SINT:

-0.40

THAR:

-0.61

Sortino Ratio

SINT:

-0.09

THAR:

-0.85

Omega Ratio

SINT:

0.99

THAR:

0.89

Calmar Ratio

SINT:

-0.90

THAR:

-0.68

Martin Ratio

SINT:

-1.13

THAR:

-1.27

Ulcer Index

SINT:

79.34%

THAR:

53.31%

Daily Std Dev

SINT:

227.09%

THAR:

111.54%

Max Drawdown

SINT:

-100.00%

THAR:

-99.88%

Current Drawdown

SINT:

-100.00%

THAR:

-99.88%

Fundamentals

Market Cap

SINT:

$3.79M

THAR:

$3.67M

EPS

SINT:

-$122.83

THAR:

$61.01

Total Revenue (TTM)

SINT:

$2.35M

THAR:

$0.00

EBITDA (TTM)

SINT:

-$8.16M

THAR:

-$8.36M

Returns By Period

In the year-to-date period, SINT achieves a -19.43% return, which is significantly lower than THAR's -6.90% return.


SINT

YTD

-19.43%

1M

-11.32%

6M

-34.42%

1Y

-90.25%

5Y*

-81.95%

10Y*

-72.24%

THAR

YTD

-6.90%

1M

-6.90%

6M

-32.26%

1Y

-67.69%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SINT vs. THAR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SINT
The Risk-Adjusted Performance Rank of SINT is 2020
Overall Rank
The Sharpe Ratio Rank of SINT is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of SINT is 2929
Sortino Ratio Rank
The Omega Ratio Rank of SINT is 2828
Omega Ratio Rank
The Calmar Ratio Rank of SINT is 22
Calmar Ratio Rank
The Martin Ratio Rank of SINT is 1717
Martin Ratio Rank

THAR
The Risk-Adjusted Performance Rank of THAR is 1212
Overall Rank
The Sharpe Ratio Rank of THAR is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of THAR is 1313
Sortino Ratio Rank
The Omega Ratio Rank of THAR is 1313
Omega Ratio Rank
The Calmar Ratio Rank of THAR is 99
Calmar Ratio Rank
The Martin Ratio Rank of THAR is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SINT vs. THAR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sintx Technologies, Inc. (SINT) and Tharimmune Inc. (THAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SINT, currently valued at -0.40, compared to the broader market-2.000.002.004.00-0.40-0.61
The chart of Sortino ratio for SINT, currently valued at -0.09, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.09-0.85
The chart of Omega ratio for SINT, currently valued at 0.99, compared to the broader market0.501.001.502.000.990.89
The chart of Calmar ratio for SINT, currently valued at -0.90, compared to the broader market0.002.004.006.00-0.90-0.68
The chart of Martin ratio for SINT, currently valued at -1.13, compared to the broader market0.0010.0020.0030.00-1.13-1.27
SINT
THAR

The current SINT Sharpe Ratio is -0.40, which is higher than the THAR Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of SINT and THAR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.70-0.60-0.50-0.40SeptemberOctoberNovemberDecember2025February
-0.40
-0.61
SINT
THAR

Dividends

SINT vs. THAR - Dividend Comparison

Neither SINT nor THAR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SINT vs. THAR - Drawdown Comparison

The maximum SINT drawdown since its inception was -100.00%, roughly equal to the maximum THAR drawdown of -99.88%. Use the drawdown chart below to compare losses from any high point for SINT and THAR. For additional features, visit the drawdowns tool.


-99.95%-99.90%-99.85%-99.80%SeptemberOctoberNovemberDecember2025February
-99.98%
-99.88%
SINT
THAR

Volatility

SINT vs. THAR - Volatility Comparison

The current volatility for Sintx Technologies, Inc. (SINT) is 9.15%, while Tharimmune Inc. (THAR) has a volatility of 13.94%. This indicates that SINT experiences smaller price fluctuations and is considered to be less risky than THAR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%SeptemberOctoberNovemberDecember2025February
9.15%
13.94%
SINT
THAR

Financials

SINT vs. THAR - Financials Comparison

This section allows you to compare key financial metrics between Sintx Technologies, Inc. and Tharimmune Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab